1.94 (-%)
As of Nov 21, 2024
Source:
ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.
| Country | United States |
| Headquarters | epalinges |
| Phone Number | 41 21 653 02 00 |
| Industry | manufacturing |
| CEO | Ameet Mallik |
| Website | www.adctherapeutics.com |